Sort   by:  
 Page size 
UnknownNew Frontiers in the Pathobiology and Treatment of Cancer Regimen-Related Mucosal Injury.
Not available
S-EPMC5462992 | biostudies-literature
UnknownKRAS and ERBB-family genetic alterations affect response to PD-1 inhibitors in metastatic nonsquamous NSCLC.
Not available
S-EPMC6859675 | biostudies-literature
UnknownFirst- and second-line treatment strategies for hormone-receptor (HR)-positive HER2-negative metastatic breast cancer: A real-world study.
Not available
S-EPMC8053791 | biostudies-literature
UnknownAssessing the effectiveness and safety of lenvatinib and everolimus in advanced renal cell carcinoma: insights from the RELIEVE study's analysis of heavily pretreated patients.
Not available
S-EPMC11025417 | biostudies-literature
UnknownInstrumental activities of daily living in older patients with metastatic prostate cancer: results from the meet-URO network ADHERE prospective study.
Not available
S-EPMC10902368 | biostudies-literature
UnknownThe Geriatric G8 Score Is Associated with Survival Outcomes in Older Patients with Advanced Prostate Cancer in the ADHERE Prospective Study of the Meet-URO Network.
Not available
S-EPMC9600362 | biostudies-literature
UnknownSignificance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.
Not available
S-EPMC10918499 | biostudies-literature
Sort   by:  
 Page size